KOVALTRY 500 IU, powder and solvent for solution for injection bottle
Active ingredients: Antihemophilic factor, human recombinant
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KOVALTRY 500 UI, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon + 1 seringue préremplie (5 mL) + 1 adaptateur pour flacon + 1 nécessaire de ponction veineuse
- Marketing authorisation holder
- BAYER AG (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65700541CIP75502720CIP133400955027201Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OCTOCOG ALFApoudre | 500 UI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.